...
首页> 外文期刊>International journal of applied mechanics >In situ hemolysis in a three-dimensional paper-based device for quantification of intraerythrocytic analytes
【24h】

In situ hemolysis in a three-dimensional paper-based device for quantification of intraerythrocytic analytes

机译:在基于三维纸的装置中的原位溶解,用于定量肾小球细胞分析物

获取原文
获取原文并翻译 | 示例

摘要

Blood-based diagnostics require various forms of sample preparation depending on the analyte of interest, which can include plasma separation and cellular lysis. Specifically, assays that require the release of intraerythrocytic analytes (e.g., detection of malaria antigens, dehydrogenases, and hemoglobin) require the rupture of red blood cells prior to analysis. Associated handling steps and additional fluid manipulation complicates the user-experience by adding time, potential for contamination error, and reagent waste. In this work, we demonstrate an in situ chemical hemolysis treatment coupled with a paper-based device for the quantification of liberated hemoglobin without using a hemolytic buffer. In contrast to traditional hemolytic methods that use a buffered solution of saponin, a surfactant, we dried saponin within our device to lyse red blood cells without diluting the sample. The optimal treatment condition for hemolysis of blood samples with hematocrit values ranging from 20-50% was 10.6 mu g saponin per cm(2). Establishing a relationship between saponin and zone area potentially allows this in situ hemolysis treatment to be translated to other paper-based devices with different geometries. For samples with hematocrit values below 40%, we achieved quantitative hemolysis. Samples with higher hematocrits (e.g., 40-50%) experienced a lesser extent of hemolysis (80-85%), which we attribute to the increased number of red blood cells present in samples with elevated hematocrits. The in situ chemical hemolysis treatment described here could potentially be integrated with a multiplexed paper-based microfluidic device to permit multiple sample preparation techniques on a single sample of blood without additional off-chip user steps.
机译:根据感兴趣的分析物,基于血基的诊断需要各种形式的样品制备,其可包括血浆分离和细胞裂解。具体地,需要释放患有细胞内分析物(例如,检测疟疾抗原,脱氢酶和血红蛋白)的测定需要在分析之前破裂红细胞。相关的处理步骤和额外的流体操作通过增加时间,污染误差和试剂废物来复杂化用户体验。在这项工作中,我们证明了一种原位化学溶解处理,其与纸型器件相结合,用于在不使用溶血缓冲液的情况下定量释放的血红蛋白。与使用皂苷的缓冲溶液的传统溶解方法形成鲜明对比,我们将在我们的装置内干燥皂苷,以溶解红细胞而不稀释样品。具有20-50%的血细胞比容值的血液样品溶血的最佳处理条件为10.6μg/厘米(2)。建立皂苷和区域之间的关系可能允许这种原位溶血处理,以翻译成具有不同几何形状的基于纸张的器件。对于具有低于40%的血细胞比容值的样品,我们实现了定量溶血。具有较高血细胞种植(例如40-50%)的样品经历了较小程度的溶血(80-85%),我们归因于血细胞比容器升高的样品中存在的红细胞数量增加。这里描述的原位化学溶解处理可能与多路复用的纸质微流体装置集成,以允许在没有额外的片外用户步骤的单个血液上进行多个样品制备技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号